rs141455061
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_030943.4(AMN):c.363G>A(p.Gly121Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00546 in 1,607,086 control chromosomes in the GnomAD database, including 64 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0059 ( 7 hom., cov: 33)
Exomes 𝑓: 0.0054 ( 57 hom. )
Consequence
AMN
NM_030943.4 synonymous
NM_030943.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.823
Genes affected
AMN (HGNC:14604): (amnion associated transmembrane protein) The protein encoded by this gene is a type I transmembrane protein. It is thought to modulate bone morphogenetic protein (BMP) receptor function by serving as an accessory or coreceptor, and thus facilitates or hinders BMP binding. It is known that the mouse AMN gene is expressed in the extraembryonic visceral endoderm layer during gastrulation, but it is found to be mutated in amnionless mouse. The encoded protein has sequence similarity to short gastrulation (Sog) and procollagen IIA proteins in Drosophila. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 14-102928825-G-A is Benign according to our data. Variant chr14-102928825-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 532207.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.823 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00588 (895/152340) while in subpopulation NFE AF= 0.00578 (393/68038). AF 95% confidence interval is 0.0053. There are 7 homozygotes in gnomad4. There are 542 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 7 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMN | NM_030943.4 | c.363G>A | p.Gly121Gly | synonymous_variant | 5/12 | ENST00000299155.10 | NP_112205.2 | |
AMN | XM_011537202.4 | c.201G>A | p.Gly67Gly | synonymous_variant | 5/12 | |||
AMN | XM_011537203.4 | c.201G>A | p.Gly67Gly | synonymous_variant | 5/12 | XP_011535505.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMN | ENST00000299155.10 | c.363G>A | p.Gly121Gly | synonymous_variant | 5/12 | 1 | NM_030943.4 | ENSP00000299155.6 |
Frequencies
GnomAD3 genomes AF: 0.00588 AC: 895AN: 152222Hom.: 7 Cov.: 33
GnomAD3 genomes
AF:
AC:
895
AN:
152222
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00595 AC: 1451AN: 243764Hom.: 16 AF XY: 0.00575 AC XY: 764AN XY: 132958
GnomAD3 exomes
AF:
AC:
1451
AN:
243764
Hom.:
AF XY:
AC XY:
764
AN XY:
132958
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00542 AC: 7887AN: 1454746Hom.: 57 Cov.: 33 AF XY: 0.00523 AC XY: 3789AN XY: 723984
GnomAD4 exome
AF:
AC:
7887
AN:
1454746
Hom.:
Cov.:
33
AF XY:
AC XY:
3789
AN XY:
723984
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00588 AC: 895AN: 152340Hom.: 7 Cov.: 33 AF XY: 0.00728 AC XY: 542AN XY: 74488
GnomAD4 genome
AF:
AC:
895
AN:
152340
Hom.:
Cov.:
33
AF XY:
AC XY:
542
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2022 | AMN: BP4, BP7 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 14, 2022 | See Variant Classification Assertion Criteria. - |
Imerslund-Grasbeck syndrome type 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 02, 2023 | - - |
Imerslund-Grasbeck syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at